Universal Health Services (NYSE:UHS) Issues Quarterly Earnings Results, Beats Expectations By $0.71 EPS

Universal Health Services (NYSE:UHS - Get Free Report) posted its earnings results on Wednesday. The health services provider reported $4.92 earnings per share for the quarter, topping analysts' consensus estimates of $4.21 by $0.71, Zacks reports. The business had revenue of $4.11 billion for the quarter, compared to analyst estimates of $4.01 billion. Universal Health Services had a return on equity of 15.75% and a net margin of 6.66%. Universal Health Services updated its FY 2025 guidance to 18.450-19.950 EPS.

Universal Health Services Stock Down 5.9 %

NYSE:UHS traded down $10.99 on Friday, hitting $175.07. The stock had a trading volume of 2,056,680 shares, compared to its average volume of 636,538. The business's fifty day moving average is $184.47 and its 200 day moving average is $204.80. The company has a market cap of $11.55 billion, a PE ratio of 11.64, a P/E/G ratio of 0.53 and a beta of 1.30. The company has a quick ratio of 1.28, a current ratio of 1.39 and a debt-to-equity ratio of 0.69. Universal Health Services has a 52 week low of $152.68 and a 52 week high of $243.25.

Universal Health Services Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, March 17th. Shareholders of record on Monday, March 3rd will be issued a $0.20 dividend. The ex-dividend date is Monday, March 3rd. This represents a $0.80 annualized dividend and a yield of 0.46%. Universal Health Services's payout ratio is currently 4.75%.

Analyst Ratings Changes

UHS has been the topic of a number of recent analyst reports. StockNews.com lowered Universal Health Services from a "strong-buy" rating to a "buy" rating in a report on Saturday, November 9th. JPMorgan Chase & Co. reaffirmed a "neutral" rating and issued a $226.00 price objective on shares of Universal Health Services in a report on Tuesday, December 17th. Wells Fargo & Company decreased their price objective on Universal Health Services from $285.00 to $230.00 and set an "overweight" rating on the stock in a report on Monday, November 25th. Bank of America assumed coverage on Universal Health Services in a report on Wednesday, November 6th. They issued a "neutral" rating and a $223.00 price objective on the stock. Finally, The Goldman Sachs Group lowered Universal Health Services from a "buy" rating to a "neutral" rating and decreased their price objective for the company from $228.00 to $198.00 in a report on Monday, December 16th. Six research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $228.77.

Insiders Place Their Bets

In other news, Director Maria Ruderman Singer sold 1,614 shares of the firm's stock in a transaction that occurred on Wednesday, December 11th. The stock was sold at an average price of $191.15, for a total value of $308,516.10. Following the transaction, the director now owns 5,879 shares in the company, valued at $1,123,770.85. This trade represents a 21.54 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 16.10% of the company's stock.

Universal Health Services Company Profile

Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.